FDA Inspection
McKesson Corporation dba RxPakMcKesson Corporation dba RxPak – FDA Inspection, Mar 1, 2010
Record Details
This FDA Inspection record concerns McKesson Corporation dba RxPak, with an inspection on March 1, 2010, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- March 1, 2010
- Product Type
- Drugs
View Company Profile
ID · 0e09a648-088a-4e9e-a4e9-0e6dc10899b7
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 650331
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
3- 21 CFR 211.25(a)Training--operations, GMPs, written procedures
- 21 CFR 211.68(b)input/output verification
- 21 CFR 211.115(b)Reprocessing/quality control unit
Full citation text and observation details available on the Dashboard.
Other FDA inspections of McKesson Corporation dba RxPak
2| Date | Classification | Office | Project area |
|---|---|---|---|
| March 22, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 27, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for McKesson Corporation dba RxPak
- FDA Inspection 1046405 - 2018-03-22
- FDA Inspection 984729 - 2016-07-27
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.